SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month. This is the first and only sirolimus drug-eluting b
SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month. This is the first and only sirolimus drug-eluting b
<iframe src="https://hindustansphere.com/embed/cluster/4753f40f2f91fa35fc0804e7e9439da1a865d11e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis"></iframe>
